glp-1 market size 2025 Receptor Agonist & Share Report, 2032 Injectable Drug Delivery Market Report

The class of medications being recommended, known formally as GLP-1 agonists, can suppress a persons appetite by mimicking a hormone that signals to the brain when a person is full

They are optimal for their insulinotropic effect exclusively when glucose levels are elevated, thereby providing the capacity to decrease plasma glucose while mitigating the risk of hypoglycemia

The most important results of these trials are summarized in Table 2

278 Muscle, Adipose Tissue and Liver Given the ability of GLP-1 to promote the incretin effect, 11,107 this hormone has indirect actions on tissues such as skeletal muscle, adipose tissue and the liver through insulin- insulin acts as a second messenger of GLP-1